Modulus Discovery, Inc. (“Modulus”), a preclinical stage technology-driven drug discovery company, will present at the 42nd Annual J.P. Morgan Healthcare Conference. The J.P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, will be held in San Francisco on January 8-11, 2024.

Roy Kimura, Modulus co-founder and CEO, will present on January 10, 2024 at 2:00 pm PST and give an update on the company’s cutting-edge simulation-based drug discovery platform and its portfolio of small-molecule drug discovery programs in chronic inflammation, autoimmune diseases, and oncology. Following the event, the company will be available for meetings with interested parties to further describe details of its unique discovery capabilities and lead programs currently in preclinical studies.